Hemostasis - general
Reviewer: Jeremy Parsons, M.D. (see Reviewers page)
Revised: 9 June 2012, last major update June 2012
Copyright: (c) 2002-2012, PathologyOutlines.com, Inc.
● Involves formation of blood clots to stop bleeding from damaged vessels, and activation of natural anticoagulation and fibrinolytic systems to limit clot formation to sites of injury
● Bleeding disorders are due to defects in clot formation or overactive fibrinolytic systems
● Hypercoagulability disorders are due to defects in anticoagulant system or underactive fibrinolytic systems
● Goodnight Jr, Scott & Hathaway (Eds) (2001). Disorders of Hemostasis & Thrombosis: A Clinical Guide: McGraw-Hill
End of Coagulation > General > Hemostasis - general
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).